September 7, 2023




United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Jason Drory, Attorney




Navidea Biopharmaceuticals, Inc.

Registration Statement on Form S-3

File No. 333-274246



Ladies and Gentlemen:


Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-274246) (the “Registration Statement”) to become effective at 4:30 p.m. Eastern Time on September 8, 2023, or as soon thereafter as is practicable.


Once the Registration Statement has been declared effective, please orally confirm that event with Bill Mower of Maslon LLP, counsel to the registrant, at (612) 672-8358.


Very truly yours,




By:   /s/ Craig Dais                                    

Craig Dais.

Chief Financial Officer


cc:  William M. Mower, Maslon LLP